Research location

Artesia

California, United States

Published trials70
Site observations70
Linked trials published70
Page1 / 2
Advertisement

Research activity in Artesia

California, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 70 trials and 70 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Artesia

70 linked trials · page 1 of 2
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular HypertensionNCT03293992 · 2017-10-10 · 1 site observation
COMPLETED
A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel StudyNCT03216902 · 2017-07-25 · 1 site observation
COMPLETED
Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHTNCT02914509 · 2016-11-07 · 1 site observation
COMPLETED
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).NCT02622334 · 2015-12-29 · 1 site observation
COMPLETED
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertNCT02537015 · 2015-08-10 · 1 site observation
COMPLETED
Bimatoprost Ocular Insert Pharmacokinetic StudyNCT02444767 · 2015-03-01 · 1 site observation
COMPLETED
Dose-Ranging Study of the Bimatoprost Ocular InsertNCT02358369 · 2015-01-19 · 1 site observation
COMPLETED
SYL040012, Treatment for Open Angle GlaucomaNCT02250612 · 2014-10-01 · 1 site observation
COMPLETED
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductNCT02143843 · 2014-06-05 · 1 site observation
COMPLETED
Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionNCT02179008 · 2014-06-01 · 1 site observation
COMPLETED
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionNCT02136940 · 2014-04-01 · 1 site observation
COMPLETED
Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular PressureNCT02057575 · 2014-01-01 · 1 site observation
COMPLETED
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionNCT01915940 · 2013-10-23 · 1 site observation
COMPLETED
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionNCT01830140 · 2013-07-01 · 1 site observation
COMPLETED
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 DaysNCT01789736 · 2013-02-01 · 1 site observation
COMPLETED
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureNCT01731002 · 2012-11-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes MellitusNCT01699737 · 2012-09-01 · 1 site observation
COMPLETED
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle GlaucomaNCT01693315 · 2012-09-01 · 1 site observation
COMPLETED
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) SubjectsNCT01668524 · 2012-08-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular HypertensionNCT01520116 · 2012-01-01 · 1 site observation
UNKNOWN
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaNCT01481051 · 2011-11-01 · 1 site observation
COMPLETED
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionNCT01410188 · 2011-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionNCT01177098 · 2010-10-01 · 1 site observation
COMPLETED
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionNCT01157364 · 2010-09-23 · 1 site observation
COMPLETED
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)NCT00877890 · 2009-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusNCT00856284 · 2009-03-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionNCT00868894 · 2009-03-01 · 1 site observation
COMPLETED
A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of DiabetesNCT00853151 · 2009-02-01 · 1 site observation
COMPLETED
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaNCT00809848 · 2009-02-01 · 1 site observation
COMPLETED
Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular HypertensionNCT00846989 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of a Glaucoma Drug Delivery SystemNCT00824720 · 2008-12-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesNCT00821977 · 2008-11-01 · 1 site observation
COMPLETED
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneNCT00763815 · 2008-09-01 · 1 site observation
COMPLETED
Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic NeuropathyNCT00693485 · 2008-09-01 · 1 site observation
COMPLETED
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle GlaucomaNCT00753168 · 2008-09-01 · 1 site observation
COMPLETED
A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or ThiazolidinedioneNCT00743002 · 2008-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusNCT00722917 · 2008-07-01 · 1 site observation
TERMINATED
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsNCT00698230 · 2008-05-01 · 1 site observation
COMPLETED
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.NCT00638742 · 2008-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular HypertensionNCT00650702 · 2008-03-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionNCT00650338 · 2008-03-01 · 1 site observation
COMPLETED
Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once DailyNCT00634842 · 2008-02-01 · 1 site observation
COMPLETED
Effect of PF-00734200 in Subjects With Type 2 DiabetesNCT00618007 · 2008-02-01 · 1 site observation
COMPLETED
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)NCT00637273 · 2008-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.NCT00572455 · 2007-12-11 · 1 site observation
COMPLETED
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveNCT00495469 · 2007-08-17 · 1 site observation
COMPLETED
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00518882 · 2007-08-01 · 1 site observation
COMPLETED
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular HypertensionNCT00527501 · 2007-08-01 · 1 site observation
COMPLETED
Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular HypertensionNCT00515424 · 2007-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.NCT00727857 · 2007-06-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.